Farraye FA, Odze RD, Eaden J, Itzkowitz SH. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138:746–74, 74.e1–4; quiz e12–3.
Klepp P, Brackmann S, Cvancarova M, Hoivik ML, Hovde Ø, Henriksen M et al. Risk of colorectal cancer in a population-based study 20 years after diagnosis of ulcerative colitis: results from the IBSEN study. BMJ Open Gastroenterol. 2020;7:e000361.
Article PubMed PubMed Central Google Scholar
Jess T, Simonsen J, Jørgensen KT, Pedersen BV, Nielsen NM, Frisch M. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology. 2012;143:375–81.e1; quiz e13–4.
Söderlund S, Brandt L, Lapidus A, Karlén P, Broström O, Löfberg R, et al. Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease. Gastroenterology. 2009;136:1561–7; quiz 818–9.
Lashner BA, Silverstein MD, Hanauer SB. Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program. Dig Dis Sci. 1989;34:1536–41.
Article CAS PubMed Google Scholar
Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. 1990;323:1228–33.
Article CAS PubMed Google Scholar
Gupta RB, Harpaz N, Itzkowitz S, Hossain S, Matula S, Kornbluth A, et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology. 2007;133:1099–105; quiz 340–1.
Matkowskyj KA, Chen ZE, Rao MS, Yang G-Y. Dysplastic lesions in inflammatory bowel disease: molecular pathogenesis to morphology. Arch Pathol Lab Med. 2013;137:338–350.
Article CAS PubMed Google Scholar
Azer SA. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development. Eur J Gastroenterol Hepatol. 2013;25:271–281.
Article CAS PubMed Google Scholar
Laine L, Kaltenbach T, Barkun A, McQuaid KR, Subramanian V, Soetikno R. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology. 2015;148:639–51.e28.
Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature. 1998;396:643–649.
Article CAS PubMed Google Scholar
Rex DK, Ahnen DJ, Baron JA, Batts KP, Burke CA, Burt RW, et al. Serrated Lesions of the colorectum: review and recommendations from an expert panel. Am Coll Gastroenterol. 2012;107:1315–29; quiz 1314, 1330.
Snover DC. Update on the serrated pathway to colorectal carcinoma. Human Pathology. 2011;42:1–10.
Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006;38:787–793.
Article CAS PubMed Google Scholar
Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76:182–188.
Parian A, Koh J, Limketkai BN, Eluri S, Rubin DT, Brant SR et al. Association between serrated epithelial changes and colorectal dysplasia in inflammatory bowel disease. Gastrointest Endosc. 2016;84:87–95.e1.
Parian AM, Limketkai BN, Chowdhury R, Brewer GG, Salem G, Falloon K et al. Serrated epithelial change is associated with high rates of neoplasia in ulcerative colitis patients: a case-controlled study and systematic review with meta-analysis. Inflamm Bowel Dis. 2021;27:1475–1481.
Jackson WE, Achkar JP, Macaron C, Lee L, Liu X, Pai RK et al. The significance of sessile serrated polyps in inflammatory bowel disease. Inflamm Bowel Dis. 2016;22:2213–2220.
Ko HM, Harpaz N, McBride RB, Cui M, Ye F, Zhang D et al. Serrated colorectal polyps in inflammatory bowel disease. Mod Pathol. 2015;28:1584–1593.
Article CAS PubMed Google Scholar
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453–1457.
Djinbachian R, Lafontaine M, Anderson JC, Pohl H, Dufault T, Boivin M, Bouin M, von Renteln D. Risk of total metachronous advanced neoplasia at surveillance colonoscopy after detection of serrated lesions: a matched cohort study. Endoscopy. 2023;55:728–736.
Vennelaganti S, Cuatrecasas M, Vennalaganti P, Kennedy KF, Srinivasan S, Patil DT et al. Interobserver agreement among pathologists in the differentiation of sessile serrated from hyperplastic polyps. Gastroenterology. 2021;160:452–4.e1.
Schachschal G, Sehner S, Choschzick M, Aust D, Brandl L, Vieth M et al. Impact of reassessment of colonic hyperplastic polyps by expert GI pathologists. Int J Colorectal Dis. 2016;31:675–683.
Howdle P, Atkin W, Rutter M, Jankowski J, Fox B, Makin C, et al. NICE Clinical Guideline 118: Colonoscopic surveillance for prevention of colorectal cancer in people with ulcerative colitis, Crohn’s disease or adenomas. NICE Publication. 2011. London: National Institute for Health and Clinical Excellence (NICE).
Schoenfeld DA. Sample-size formula for the proportional-hazards regression model. Biometrics. 1983;39:499–503.
Article CAS PubMed Google Scholar
Lash RH, Genta RM, Schuler CM. Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients. J Clin Pathol. 2010;63:681–686.
Leddin D, Enns R, Hilsden R, Fallone CA, Rabeneck L, Sadowski DC et al. Colorectal cancer surveillance after index colonoscopy: guidance from the Canadian Association of Gastroenterology. Can J Gastroenterol. 2013;27:224–228.
Article PubMed PubMed Central Google Scholar
Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008;58:130–160.
Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012;143:844–857.
Gupta S, Lieberman D, Anderson JC, Burke CA, Dominitz JA, Kaltenbach T et al. Recommendations for follow-up after colonoscopy and polypectomy: a consensus update by the US multi-society task force on colorectal cancer. Gastroenterology. 2020;158:1131–53.e5.
Hassan C, Antonelli G, Dumonceau JM, Regula J, Bretthauer M, Chaussade S et al. Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline—Update 2020. Endoscopy. 2020;52:687–700.
Annese V, Beaugerie L, Egan L, Biancone L, Bolling C, Brandts C et al. European evidence-based consensus: inflammatory bowel disease and malignancies. J Crohns Colitis. 2015;9:945–965.
Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis. 2017;11:649–70.
Shen J, Gibson JA, Schulte S, Khurana H, Farraye FA, Levine J et al. Clinical, pathologic, and outcome study of hyperplastic and sessile serrated polyps in inflammatory bowel disease. Hum Pathol. 2015;46:1548–1556.
Crockett SD, Nagtegaal ID. Terminology, molecular features, epidemiology, and management of serrated colorectal neoplasia. Gastroenterology. 2019;157:949–66.e4.
Hyun E, Helewa RM, Singh H, Wightman HR, Park J. Serrated polyps and polyposis of the colon: a brief review for surgeon endoscopists. Can J Surg. 2021;64:E561.
Article PubMed PubMed Central Google Scholar
Jaravaza DR, Rigby JM. Hyperplastic polyp or sessile serrated lesion? The contribution of serial sections to reclassification. Diagn Pathol. 2020;15:140.
Comments (0)